An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease.
Medi
C
C
Concord Hospital, Cardiology, Sydney, New South Wales, Australia. caroline.medi@mh.org.au
Chew
D P B
DP
Amerena
J
J
Coverdale
S
S
Soman
A
A
Astley
C
C
Rankin
J
J
Brieger
D
D
D054058:Acute Coronary Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D058186:Acute Kidney Injury / Q000453:epidemiology / Q000209:etiology; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003131:Combined Modality Therapy; D017023:Coronary Angiography / Q000706:statistics & numerical data; D019468:Disease Management; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006801:Humans; D015994:Incidence; D053208:Kaplan-Meier Estimate; D007674:Kidney Diseases / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization / Q000706:statistics & numerical data; D009517:New South Wales / Q000453:epidemiology; D012306:Risk; D015983:Selection Bias; D016896:Treatment Outcome
D015415:Biomarkers; D002317:Cardiovascular Agents